Exosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenues

Show simple item record

dc.contributor.author Marima, Rahaba
dc.contributor.author Basera, Afra
dc.contributor.author Miya, Thabiso Victor
dc.contributor.author Damane, Botle Precious
dc.contributor.author Kandhavelu, Jeyalakshmi
dc.contributor.author Mirza, Sheefa
dc.contributor.author Penny, Clement
dc.contributor.author Dlamini, Zodwa
dc.date.accessioned 2025-02-28T07:08:35Z
dc.date.available 2025-02-28T07:08:35Z
dc.date.issued 2024-09
dc.description.abstract In the intricate field of cancer biology, researchers are increasingly intrigued by the emerging role of exosomal long non-coding RNAs (lncRNAs) due to their multifaceted interactions, complex modulation mechanisms, and potential therapeutic applications. These exosomal lncRNAs, carried within extracellular vesicles, play a vital partin tumorigenesis and disease progression by facilitating communication networks between tumor cells and their local microenvironment, making them an ideal candidates for use in a liquid biopsy approach. However, exosomal lncRNAs remain an understudied area, especially in cancer biology. Therefore this review aims to comprehensively explore the dynamic interplay between exosomal lncRNAs and various cellular components, including interactions with tumor-stroma, immune modulation, and drug resistance mechanisms. Understanding the regulatory functions of exosomal lncRNAs in these processes can potentially unveil novel diagnostic markers and therapeutic targets for cancer. Additionally, the emergence of RNA-based therapeutics presents exciting opportunities for targeting exosomal lncRNAs, offering innovative strategies to combat cancer progression and improve treatment outcomes. Thus, this review provides insights into the current understanding of exosomal lncRNAs in cancer biology, highlighting their crucial roles, regulatory mechanisms, and the evolving landscape of therapeutic interventions. Furthermore, we have also discussed the advantage of exosomes as therapeutic carriers of lncRNAs for the development of personalized targeted therapy for cancer patients. en_US
dc.description.department Medical Oncology en_US
dc.description.department Surgery en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The University of Pretoria (UP) Research Development Programme (RDP); UP Development Fund; The South African Medical Research Council (SAMRC); the National Research Foundation (NRF). en_US
dc.description.uri http://www.keaipublishing.com/en/journals/non-coding-rna-research en_US
dc.identifier.citation Marima, R., Basera, A., Miya, T. et al. 2024, 'Exosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenues', Non-coding RNA Research, vol. 9, pp. 887-900. https://DOI.org/10.1016/j.ncrna.2024.03.014. en_US
dc.identifier.issn 2468-0540
dc.identifier.other 10.1016/j.ncrna.2024.03.014
dc.identifier.uri http://hdl.handle.net/2263/101274
dc.language.iso en en_US
dc.publisher KeAi Communications Co. en_US
dc.rights © 2024 The Authors. This is an open access article under the CC BY-NC-ND license. en_US
dc.subject Exosomes en_US
dc.subject Exosomal lncRNAs en_US
dc.subject Cancer en_US
dc.subject Intercellular and intracellular communication en_US
dc.subject Biomarkers en_US
dc.subject Long non-coding RNAs (lncRNAs) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Exosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenues en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record